STOCK TITAN

ANAPTYSBIO INC (ANABV) Net Income by Year

ANABV

ANAPTYSBIO INC reported a net loss of $13.2M in fiscal year 2025. This represents an increase of 90.9% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to a $26.8M net loss. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters ANAPTYSBIO INC has filed alongside them.

FY2025 annual
Net Income -$13.2M
YoY +90.9%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ANABV Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16FY15
Net Income-$26.8M-$13.2M+90.9%-$145.2M+11.2%-$163.6M-27.1%-$128.7M-122.7%-$57.8M-190.0%-$19.9M+79.5%-$97.3M-57.9%-$61.7M-105.0%-$30.1M-606.0%-$4.3M+21.2%-$5.4M

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

ANABV Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Net Income-$52.9M-34.5%$49.6M+327.8%$15.1M+146.0%-$38.6M+17.2%-$39.3M+10.5%-$21.8M+48.4%-$32.9M+11.9%-$46.7M-17.1%-$43.9M+0.7%-$42.2M-59.8%-$37.3M-11.4%-$39.8M-22.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ANAPTYSBIO INC financials

Frequently Asked Questions

What was ANAPTYSBIO INC's net income in fiscal year 2025?

ANAPTYSBIO INC reported a net loss of $13.2M in fiscal year 2025.

How fast is ANAPTYSBIO INC's net income growing?

ANAPTYSBIO INC (ANABV) net income rose by 90.9% year over year, from -$145.2M to -$13.2M in fiscal year 2025.

What is ANAPTYSBIO INC's net income over the last twelve months?

ANAPTYSBIO INC (ANABV) reported a $26.8M net loss over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, ANAPTYSBIO INC (ANABV) net income went from -$5.4M in fiscal year 2015 to -$13.2M in fiscal year 2025.

ANAPTYSBIO INC (ANABV) reported -$52.9M in net income in Q1 2026. This represents a decrease of 34.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ANAPTYSBIO INC (ANABV) reported on that line in every period on record.